TrialStem cells and development2020
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
Vikram Sengupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
455 papers cite itlatest 60 shown
this paperpooled ittrialcites it